Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Master's Award: Canada Graduate Scholarships

McGill University

$27,000.00

Wharton’s Jelly Mesenchymal Stem Cells as a Regenerative Therapy for Radiation-Induced Xerostomia in Head and Neck Cancer Patients

FY 2024-25

Summary
Head and Neck Squamous Cell Carcinoma (HNSCC) is the sixth most common cancer worldwide, and radiotherapy, its standard treatment, often results in irreversible damage to the salivary glands (SG). A serious consequence of irradiation (IR) to the head and neck region is dry mouth (xerostomia), which impairs essential functions including swallowing and speaking, while increasing the risk of oral infections and ulcerations. These symptoms severely affect the quality of life for HNSCC patients, as current therapies only provide symptomatic relief using saliva substitutes and stimulants, with no curative options available. To address this critical gap, we propose a regenerative medicine approach utilizing mesenchymal stem cells (MSCs) derived from Wharton's Jelly (WJ-MSCs) to restore SG function following IR. WJ-MSCs, isolated from the umbilical cord, offer several advantages, including robust regenerative potential, immunomodulatory properties, and a non-tumorigenic profile, making them a safer, and more effective alternative to other stem cell types such as those derived from the bone marrow or adipose tissue. This study aims to evaluate the safety and efficacy of WJ-MSCs in a preclinical mouse model, targeting the restoration of SG tissue and glandular function. We hypothesize that direct injection of WJ-MSCs into irradiation-injured SGs will facilitate tissue repair and functional recovery. If successful, this strategy could translate into clinical practice as a scalable, minimally invasive, off-the-shelf treatment, with the potential to improve the quality of life for millions of patients worldwide undergoing radiotherapy for HNSCC.
Program
Master's Award: Canada Graduate Scholarships
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
530246
Name
Chen Nina
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Wharton’s Jelly Mesenchymal Stem Cells as a Regenerative Therapy for Radiation-Induced Xerostomia in Head and Neck Cancer Patients
Programtype2
Studentship Programs
Orgnameinp2
McGill University
Cihramount2
$27,000
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Head And Neck Cancer; Hyposalivation; Irradiation; Radiotherapy; Regenerative Medicine; Salivary Gland Dysfunction; Salivary Gland Regeneration; Stem Cell Therapy; Wharton'S Jelly Mesenchymal Stem Cells; Xerostomia
Abstract
Head and Neck Squamous Cell Carcinoma (HNSCC) is the sixth most common cancer worldwide, and radiotherapy, its standard treatment, often results in irreversible damage to the salivary glands (SG). A serious consequence of irradiation (IR) to the head and neck region is dry mouth (xerostomia), which impairs essential functions including swallowing and speaking, while increasing the risk of oral infections and ulcerations. These symptoms severely affect the quality of life for HNSCC patients, as current therapies only provide symptomatic relief using saliva substitutes and stimulants, with no curative options available. To address this critical gap, we propose a regenerative medicine approach utilizing mesenchymal stem cells (MSCs) derived from Wharton's Jelly (WJ-MSCs) to restore SG function following IR. WJ-MSCs, isolated from the umbilical cord, offer several advantages, including robust regenerative potential, immunomodulatory properties, and a non-tumorigenic profile, making them a safer, and more effective alternative to other stem cell types such as those derived from the bone marrow or adipose tissue. This study aims to evaluate the safety and efficacy of WJ-MSCs in a preclinical mouse model, targeting the restoration of SG tissue and glandular function. We hypothesize that direct injection of WJ-MSCs into irradiation-injured SGs will facilitate tissue repair and functional recovery. If successful, this strategy could translate into clinical practice as a scalable, minimally invasive, off-the-shelf treatment, with the potential to improve the quality of life for millions of patients worldwide undergoing radiotherapy for HNSCC.
Competitiondate
202412
Approvedterm2
1 yr 0 mth
Pinamesdelim
Chen, Nina
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $27,000~ $0~